A team of researchers from the Hospital del Mar Research Institute, the Universitat Autònoma de Barcelona and the Pompeu Fabra University has developed a new tool that allows modifying these NK cells ...

Muzastotug Phase 2 dose expansion in MSS CRC with a 20 mg/kg loading dose regimen shows 33% overall response rate with four confirmed partial ...

Consistent with ongoing initiatives to prudently manage its cash balance, Adagene (ADAG) expects its current cash balance to fund activities ...

These pages give an overview of what genes are and how they are involved in the different diseases that cause dementia. You will also find information about genetic testing for dementia. Genes ...

In the last year, some drugmakers have pulled back from the sector, including Pfizer, which recently stopped selling its gene ...